Class Action Lawsuit Filed Against Hims & Hers Health Over Data Practices

The complaint centers on claims that Hims & Hers failed to disclose the sharing of sensitive consumer health information with third-party advertising platforms. Furthermore, the suit alleges the company charged customers for prescriptions almost immediately after they submitted intake forms, contradicting claims that medical consultations would determine the appropriate treatment for each individual. These omissions allegedly exposed the company to increased regulatory scrutiny and potential financial penalties.

Investors who suffered losses during this period have until November 1, 2026, to request appointment as lead plaintiff. While the firm operates on a contingency fee basis, meaning costs are only recovered if the case succeeds, those wishing to review the full complaint or seek further information can reach Peretz Bronstein or Nathan Miller at 917-590-0911.